Psychometric Testing of the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-CIPN20 Using Pooled Chemotherapy-Induced Peripheral Neuropathy Outcome Measures Standardization (CI-PeriNomS) and Alliance for Clinical Trials in Oncology (Alliance) A151408 Study Data

BACKGROUND: No gold-standard patient-reported outcome measure of chemotherapy-induced peripheral neuropathy (CIPN) exists. OBJECTIVE: To re-evaluate the sensitivity, reliability, and validity of the European Organisation for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire–Chem...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Nurs
Autors principals: Lavoie Smith, Ellen M., Banerjee, Tanima, Yang, James J., Bridges, Celia M., Alberti, Paola, Sloan, Jeff A., Loprinzi, Charles
Format: Artigo
Idioma:Inglês
Publicat: 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6185825/
https://ncbi.nlm.nih.gov/pubmed/29649081
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/NCC.0000000000000596
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars